Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 06/16/21 → 10/29/25 |
Funding
- Boehringer Ingelheim Pharmaceutical: $106,405.00
EMPACT-MI: A Streamlined, Multicentre, Randomized, Parallel Group, Double-blind Placebo-Controlled Superiority Trial to Evaluate the Effect of EMP Agliflozin on Hospitalization for Heart Failure and Mortallity in Patients with aCutTE Myoca
- Chen, On (PI)
- Skopicki, Hal A (CoPI)
Project: Research